We manufacture and market a large basket of pharmaceutical formulations across chronic and acute therapies, including generics, branded generics, specialty & complex products, over-the-counter (OTC), antiretrovirals (ARV), Active Pharmaceutical Ingredients (API), and intermediates. Our portfolio spans multiple dosage forms such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids. With billions of doses delivered annually across our key therapeutic areas like neuro-psychiatry, cardiology, gastroenterology, anti-infectives diabetology, oncology, ophthalmology, dermatology, urology, nephrology, respiratory, and more, we are helping improve access to medicine globally.
Recent Posts
- Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
- Sun Pharma and LIB Therapeutics announce global licensing agreement for Lerodalcibep
- Sun Pharma Launches CTaro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
- Sun Pharma reports Q1FY27 results
- Sun Pharma receives approval to manufacture and market semaglutide in Brazil
Recent Comments